Products Archive | AGP Pharma

Bilazest

Generic:

Bilastine

Therapeutic Class:

Antihistamines Systemic

Composition:

Each Bilazest tablet contains Bilastine 20 mg.

Description:

Bilazest (Bilastine) is a second-generation antihistamine, used to treat urticaria & allergic rhinitis.

Indications:

Seasonal Allergic Rhinitis:
It is indicated for the symptomatic relief of nasal and non-nasal symptoms of seasonal allergic rhinitis in patients 12 years of age and older.

Chronic Spontaneous Urticaria:
It is indicated for the relief of the symptoms associated with chronic spontaneous urticaria (e.g. pruritus and hives), in patients 18 years of age and older.

Dosage:

Recommended daily dose:

Seasonal Allergic Rhinitis ≥ 12 years: 1 tablet once daily
Chronic Spontaneous Urticaria ≥ 18 years: 1 tablet once daily

Presentations:

Bilazest Tab is available in packs of 10’s.

Vita-NEM Plus

Generic:

Natural Eggshell Membrane, Cholecalciferol (Vit D3), Menaquinone-7 (Vit K2), Zinc.

Therapeutic Class:

Other Musculoskeletal Products.

Composition:

Each Vita-NEM Plus capsule contains:

• Natural Eggshell Membrane 300 mg
• Cholecalciferol 5 mcg
• Menaquinone-7 15 mcg
• Zinc 5 mg

Description:

Vita-NEM Plus contains Natural Eggshell Membrane (Collagen, Hyaluronic acid, Glucosamine & Chondroitin sulfate), Cholecalciferol (Vit D3), Menaquinone-7 (Vit K2) & Zinc.

Indications:

Vita-NEM Plus is useful for:

• Alleviating arthritis symptoms.
• Relieving joint pain and improving range of motion.
• Supporting joint health as it contains Natural Eggshell membrane (collagen, glucosamine, chondroitin, hyaluronic acid), Cholecalciferol (Vit D3), Menaquinone-7 (Vit K2) & Zinc.

Dosage:

One capsule daily or as directed by the physician.

Presentations:

Vita-NEM Plus cap is available in packs of 10’s.

Mychitol Plus

Generic:

Myo Inositol, D-chiro-Inositol, Manganese, L-Methyl-Folate

Therapeutic Class:

Other Gynecological Products

Composition:

Each Mychitol Plus sachet contains:

• Myo Inositol 2000 mg
• D-chiro-Inositol 50 mg
• Manganese 10 mg
• L-Methyl-Folate 400 mcg

Description:

Mychitol Plus sachet is a dietary supplement to treat PCOS (Polycystic ovary syndrome) & its complications.

Indications:

• Helps alleviate PCOS.
• Reduces hyperandrogenism.
• Regulates menstrual cycle disorders
• Induces Ovulation
• Reduces the risk of GDM (Gestational diabetes mellitus)
• Manages anemia due to folic acid deficiency
• Prevents neural tube defects
• Manganese acts as anti-oxidant

Dosage:

1 to 2 Sachets daily.

Presentations:

Mychitol Plus sachet is available in the Pack of 10’s.

Soda Cran

Generic:

Cranberry Extract

Therapeutic Class:

Urinary Anti-Infectives

Composition:

Each Soda Cran sachet contains:

Vaccinium Macrocarpone (Cranberry dry fruit juice) …368.30 mg
Sodium Bicarbonate … 2176.7 mg
Tartaric acid … 630 mg
Citric acid anhydrous …1000 mg
Sodium Citrate anhydrous …625 mg

Description:

Soda Cran contains cranberry extract with an alkalizing activity.

Indications:

• Urinary tract infections
• Pain, irritation, and burning sensation in the urinary tract
• Adhesion of E. coli to the urinary tract
• Helps to prevent Gut Acidity
• Helps to prevent uric acid and kidney stones

Dosage:

Use 2-4 sachets daily, dissolve one sachet in a glass of water, and use immediately.

Presentations:

Soda Cran Sachet is available in a pack of 10’s.

AG-Cetam

Generic:

Levetiracetam

Therapeutic Class:

Anti Epileptics

Composition:

Each AG-Cetam tablet contains 250 mg or 500 mg of levetiracetam.
AG-Cetam solution contains 100 mg of levetiracetam per mL.
AG-Cetam Inj contains 500 mg of levetiracetam per 5 ml.

Description:

AG-Cetam (Levetiracetam) is an anti-epileptic drug (anticonvulsant) often used in conjunction with other drugs to treat types of seizures in people with epilepsy.

Indications:

Partial Onset Seizures

Indicated as adjunctive therapy in the treatment of partial onset seizures in adults and children 1 month of age and older with epilepsy.

Myoclonic Seizures in Patients with Juvenile Myoclonic Epilepsy

Indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents 12 years of age and older with juvenile myoclonic epilepsy.

Primary Generalized Tonic-Clonic Seizures

Indicated as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in adults and children 6 years of age and older with idiopathic generalized epilepsy.

Dosage:

Dosing For Partial Onset Seizures

Adults 16 Years and Older:

Initiate treatment with a daily dose of 1000 mg/day, given as twice-daily dosing (500 mg twice daily). Additional dosing increments may be given (1000 mg/day additional every 2 weeks) to a maximum recommended daily dose of 3000 mg. There is no evidence that doses greater than 3000 mg/day confer additional benefit.

Pediatric Patients:

One month to < 6 months: Initiate treatment with a daily dose of 14 mg/kg in 2 divided doses (7 mg/kg twice daily). Increase the daily dose every 2 weeks by increments of 14 mg/kg to the recommended daily dose of 42 mg/kg (21 mg/kg twice daily).

6 months to < 4 years: Initiate treatment with a daily dose of 20 mg/kg in 2 divided doses (10 mg/kg twice daily). Increase the daily dose in 2 weeks by an increment of 20 mg/kg to the recommended daily dose of 50 mg/kg (25 mg/kg twice daily). If a patient cannot tolerate a daily dose of 50 mg/kg, the daily dose may be reduced.

4 years to < 16 years: Initiate treatment with a daily dose of 20 mg/kg in 2 divided doses (10 mg/kg twice daily). Increase the daily dose every 2 weeks by increments of 20 mg/kg to the recommended daily dose of 60 mg/kg (30 mg/kg twice daily). If a patient cannot tolerate a daily dose of 60 mg/kg, the daily dose may be reduced.

Pediatric patients weighing 20 to 40 kg: Initiate treatment with a daily dose of 500 mg given as twice daily dosing (250 mg twice daily). Increase the daily dose every 2 weeks by increments of 500 mg to a maximum recommended daily dose of 1500 mg (750 mg twice daily).

Pediatric patients weighing more than 40 kg: Initiate treatment with a daily dose of 1000 mg/day given as twice daily dosing (500 mg twice daily). Increase the daily dose every 2 weeks by increments of 1000 mg/day to a maximum recommended daily dose of 3000 mg (1500 mg twice daily).

Weight-Based Dosing Calculation for Oral Solution in Pediatric Patients

The following calculation should be used to determine the appropriate daily dose of oral solution for pediatric patients:

Total daily dose (mL/day) = Daily dose (mg/kg/day) x patient weight (kg) / 100 mg/mL

Dosing for Myoclonic Seizures in Patients 12 Years of Age and Older with Juvenile Myoclonic Epilepsy
Initiate treatment with a dose of 1000 mg/day, given as twice-daily dosing (500 mg twice daily). Increase the dosage by 1000 mg/day every 2 weeks to the recommended daily dose of 3000 mg. The effectiveness of doses lower than 3000 mg/day has not been studied.

Dosing for Primary Generalized Tonic-Clonic Seizures

Adults 16 Years and Older:

Initiate treatment with a dose of 1000 mg/day, given as twice-daily dosing (500 mg twice daily). Increase dosage by 1000 mg/day every 2 weeks to the recommended daily dose of 3000 mg. The effectiveness of doses lower than 3000 mg/day has not been adequately studied.

Pediatric Patients ages 6 to < 16 years

Initiate treatment with a daily dose of 20 mg/kg in 2 divided doses (10 mg/kg twice daily). Increase the daily dose every 2 weeks by increments of 20 mg/kg to the recommended daily dose of 60 mg/kg (30 mg/kg twice daily). The effectiveness of doses lower than 60 mg/kg/day has not been adequately studied.

Patients with body weight ≤ 20 kg: Prescribe oral solution.

Patients with body weight above 20 kg: Prescribe tablets or oral solution.

Presentations:

AG-Cetam Tab 250 mg & 500 mg are available in blister the packs of 10’s.
AG-Cetam Sol 100 mg/ml is available in a bottle of 60 ml.
AG-Cetam Inj 500 mg/5ml is available in the pack of 1’s.

AG-Vono

Generic:

Vonoprazan

Therapeutic Class:

Proton Pump Inhibitor

Composition:

Each AG-Vono tablet contains 10 mg or 20 mg of Vonoprazan.

Description:

AG-Vono (Vonoprazan) is a first-in-class potassium-competitive acid blocker medication.

Indications:

AG-Vono is indicated for:

Treatment of gastric ulcer
Treatment of duodenal ulcer
Treatment of reflux esophagitis
Maintenance treatment of reflux esophagitis in patients with repeat recurrence and relapse of the condition
Prevention of recurrence of gastric ulcer or duodenal ulcer during NSAIDs administration
Adjunctive effect on eradication of Helicobacter pylori

Dosage:

Adults

Gastric ulcer
• The usual dose is AG-Vono Tab 20 mg once daily. Administration – Limited to 8 weeks.Duodenal ulcer
• The usual dose is AG-Vono Tab 20 mg once daily. Administration – Limited to 6 weeks.

Reflux esophagitis (erosive esophagitis)
• The usual dose is AG-Vono Tab 20 mg once daily. Administration – Limited to 4 – 8 weeks.

• In addition, for the maintenance of healing of reflux esophagitis in patients with repeat recurrence and relapse of the condition, a dose of AG-Vono Tab 10 mg is administered once daily; however, when the efficacy is inadequate, a dose of AG-Vono Tab 20 mg may be administered once daily. The duration of administration in the long-term efficacy clinical Study is up to 52 weeks.

Prevention of recurrence of gastric ulcer or duodenal ulcer during NSAIDs administration
• The usual dose is AG-Vono Tab 10 mg once daily.

Adjunct to Helicobacter pylori eradication
• Usually, the following 3 drugs are orally administered at the same time twice daily for 7 days: AG-Vono Tab 20 mg, 750 mg amoxicillin, and 200 mg clarithromycin. The dose of clarithromycin may be appropriately increased as required, however, the upper limit is 400 mg twice daily.

• If the treatment with 3 drugs consisting of a proton pump inhibitor, amoxicillin, and clarithromycin fails, alternative treatment with the following 3 drugs is recommended; AG-Vono Tab 20 mg, 750 mg amoxicillin, and 250 mg metronidazole, orally administered at the same time twice daily for 7 days. The doses of antibiotic should follow the respective label recommendations for H. pylori eradication.

Presentations:

AG-Vono Tab 10 mg & Tab 20 mg are available in blister pack of 14’s

PeriDots

Generic:

Peppermint oil, Spearmint oil

Therapeutic Class:

Menthae Piperitae Aetheroleum

Composition:

Each PeriDots soft gelatin capsule contains:

Peppermint oil .……………. 0.174 ml
Spearmint oil ……………. 0.034 ml

Description:

Peppermint oil is the essential oil taken from the flowering parts and leaves of the peppermint plant. Peppermint is used to treat a variety of digestive problems such as heartburn and acidity. Also, it has antispasmodic activity. It provides quick relief from acidity, bloating, etc. Effective solution for indigestion and pain.

Indications:

Indigestion
Heartburn
Acidity
Excessive gas
Abdominal spasm and colic pain

Dosage:

To be taken after a meal with a glass of water.
1 capsule: 2-3 times daily
Not recommended for children below 12 years of age

Presentations:

PeriDots Cap is available in packs of 30’s.

Rozet EZ

Generic:

Rosuvastatin, Ezetimibe

Therapeutic Class:

Lipid Modifying Agents, Combinations

Composition:

Rozet EZ Tab 5 mg / 10 mg: Each tablet contains 5 mg Rosuvastatin and 10 mg Ezetimibe.
Rozet EZ Tab 10 mg / 10 mg: Each tablet contains 10 mg Rosuvastatin and 10 mg Ezetimibe.
Rozet EZ Tab 20 mg / 10 mg: Each tablet contains 20 mg Rosuvastatin and 10 mg Ezetimibe.

Description:

Rozet EZ tablets contain rosuvastatin calcium and ezetimibe. Rosuvastatin is a 3-hydroxy-3methylglutaryl coenzyme A (HMG CoA)-reductase inhibitor. Ezetimibe is a dietary cholesterol absorption inhibitor.

Indications:

As an adjunct to diet in patients with primary non-familial hyperlipidemia to reduce low-density lipoprotein cholesterol (LDL-C).
Alone or as an adjunct to other LDL-C-lowering therapies in patients with homozygous familial hypercholesterolemia (HoFH) to reduce LDL-C.

Dosage:

The dosage range is 5 mg/10 mg to 40 mg/10 mg once daily.

The recommended dose of Rozet EZ depends on a patient’s indication for usage, LDL-C, and individual risk for cardiovascular events.
The starting dosage for patients switching to Rozet EZ from co-administration of a statin and ezetimibe is based on an equivalent dose of rosuvastatin and 10 mg of ezetimibe.
Assess LDL-C when clinically appropriate, as early as 2 weeks after initiating Rozet EZ, and adjust the dosage if necessary.

Presentations:

Rozet EZ Tab 5 mg /10 mg is available in a pack of 10’s
Rozet EZ Tab 10 mg /10 mg is available in a pack of 10’s
Rozet EZ Tab 20 mg /10 mg is available in a pack of 10’s

Xiton

Generic:

Risperidone

Therapeutic Class:

Atypical Antipsychotics

Composition:

Each Xiton tablet contains risperidone 1 mg, 2 mg, 3 mg or 4 mg as active ingredient
Each ml of Xiton oral solution contains risperidone 1 mg

Description:

Xiton (Risperidone), an atypical antipsychotic belongs to the chemical class of benzisoxazole derivatives.

Indications:

Schizophrenia
Bipolar Mania
- Monotherapy: Acute manic or mixed episodes associated with Bipolar I Disorder.
- Adjunctive Therapy: With lithium or valproate is indicated for the treatment of acute manic or mixed episodes associated with Bipolar I Disorder.
Irritability Associated with Autistic Disorder

Dosage:

	Initial Dose	Titration (Increments)	Target Dose	Effective Dose Range
Schizophrenia: Adults	2 mg	1 to 2 mg	4 to 8 mg	4 to 16 mg
Schizophrenia: Adolescents	0.5 mg	0.5 to 1 mg	3 mg	1 to 6 mg
Bipolar Mania: Adults	2 to 3 mg	1 mg	1 to 6 mg	1 to 6 mg
Bipolar Mania: Children and Adolescents	0.5 mg	0.5 to 1 mg	1 to 2.5 mg	1 to 6 mg
Irritability in Autistic Disorder	0.25 mg Can increase to 0.5 mg by Day 4: (body weight less than 20 kg) 0.5 mg Can increase to 1 mg by Day 4: (body weight greater than or equal to 20 kg)	After Day 4, at intervals of > 2 weeks: 0.25 mg (body weight less than 20 kg) 0.5 mg (body weight greater than or equal to 20 kg)	0.5 mg: (body weight less than 20 kg) 1 mg: (body weight greater than or equal to 20 kg)	0.5 to 3 mg

Presentations:

Xiton Tabs 1 mg, 2 mg, 3 mg or 4 mg are available in pack of 10’s.
Xiton Oral Solution is available in 60 ml bottle.

Xedexo

Generic:

Olanzapine, Fluoxetine

Therapeutic Class:

Psycholeptic Antidepressant

Composition:

Xedexo Cap 3 mg/ 25 mg: Each capsule contains 3 mg Olanzapine with 25 mg Fluoxetine.
Xedexo Cap 6 mg/ 25 mg: Each capsule contains 6 mg Olanzapine with 25 mg Fluoxetine.

Description:

Xedexo contains Olanzapine and Fluoxetine an atypical antipsychotic and a selective serotonin reuptake inhibitor.

Indications:

• Acute depressive episodes in Bipolar I Disorder
• Treatment resistant depression (Major Depressive Disorder in patient who do not respond to 2 separate trials of different antidepressants of adequate dose and duration in the current episode)

Dosage:

Depressive Episodes Associated with Bipolar I Disorder:

Adults: One capsule daily in the evening, generally beginning with the 6 mg/25 mg capsule.

Children and adolescents (10 to 17 years of age): One capsule daily in the evening, generally beginning with the 3 mg/25 mg capsule.

Treatment Resistant Depression:

Administer one capsule daily in the evening, generally beginning with the 6 mg/25 mg capsule. Adjust dosage, if indicated, according to efficacy and tolerability.

Presentations:

Xedexo Cap 3 mg/25 mg & 6 mg/25 mg are available in pack of 14’s